跳至主要内容
临床试验/CTRI/2018/04/013072
CTRI/2018/04/013072招募中未知

A pilot study to evaluate systemic availablity of oral therapeutic agent somal (Arsenic Trioxide) in cancer patients

Rasayani Cancer Clinics Pune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. male or female cancer patient aged 20 to 70 years.
  • 2.Cancer Patients who has expected survival of more than 3 months.
  • 3.Cancer Patients who are not willing to take chemotherapy/eligible to take chemotherapy.
  • 4.Cancer patients who are eligible to receive treatment of Somal.
  • 5. Cancer patient who are willing to take ayurvedic treatment for cancer and provide consent for the same.

排除标准

  • 1.Patients taking Chemotherapy
  • 2.Patients taking conventional products containing Arsenic
  • 3.Patient with deranged hepatic or renal profile at baseline.
  • 4.Patients with Pre-existing cardiac illness
  • Patients who has ECOG performance is > 2

研究者

发起方
Rasayani Cancer Clinics Pune

相似试验